testosterone/悪性腫瘍

U.S. GOVERNMENT SUPPORT Not applicable. BACKGROUND OF THE INVENTION 1. Area of the Background This invention is generally in the area of urology and more specifically in improved treatment and outcome for radical prostatectomy surgery. 2. Description of the Background Low testosterone level

BACKGROUND Testosterone, delivered by subcutaneous pellet implant has been used in the United States, Europe and Australia in both men and women to treat symptoms of testosterone deficiency. Symptoms of testosterone hormone deficiency include fatigue, lack of energy, depression, memory loss,

BACKGROUND OF THE INVENTION A. Field of the Invention The invention relates to the use of nutrient combinations to prevent or reduce potential adverse effects from administration of androgenic testosterone precursors to humans and other mammals Specifically, the invention relates to

FIELD OF THE INVENTION The present invention relates in general to compositions and methods for treatment of cancer. More specifically, the invention provides compositions and methods for treating diseases such as cancer by disrupting the luteinizing hormone (LH)/luteinizing hormone receptor (LHR)

Prostate cancer is a leading cause of morbidity and mortality for men in the industrialized world. The American Cancer Society estimates that during 2007 about 218,890 new cases of prostate cancer will have been diagnosed in the United States alone. Prostate cancer is the second leading cause of

Prostate cancer is a leading cause of morbidity and mortality for men in the industrialized world. The American Cancer Society estimates that during 2007 about 218,890 new cases of prostate cancer will have been diagnosed in the United States alone. Prostate cancer is the second leading cause of

Prostate cancer is a leading cause of morbidity and mortality for men in the industrialized world. The American Cancer Society estimates that during 2007 about 218,890 new cases of prostate cancer will have been diagnosed in the United States alone. Prostate cancer is the second leading cause of

This application is a National Stage application of PCT/JP94/00406, filed Mar. 14, 1994, which published as WO94/22821 on Oct. 13, 1994. TECHNICAL FIELD The present invention relates to novel indole derivatives and pharmaceutically acceptable salts thereof. More particularly, it relates to novel

FIELD OF THE INVENTION This invention relates to pharmaceutical compositions and methods for the treatment of androgen-related diseases, said compositions having novel inhibitors of testosterone 5.alpha.-reductase activity. The inhibitors have a good combination of inhibitory effect on

TECHNICAL FIELD The present invention relates to novel methods for conferring neuroprotection on a subject that relies on administering an effective dose of at least one testosterone inhibitor. BACKGROUND TO THE INVENTION Neurodegenerative diseases have a major impact on society. For example,

BACKGROUND OF THE INVENTION Prostate cancer is the most commonly diagnosed cancer in American men and the second most common cause of death from cancer in American men. Androgen withdrawal, by castration or through the use of an anti-androgenic drug, is the preferred treatment method for prostate

FIELD OF THE INVENTION This application relates to a method and compositions for chemosensitization and radiosensitization of cancer cells through administration of compositions, such as antisense oligonucleotides, which reduce the amount of TRPM-2 in the cells. The invention is of particular

FIELD OF THE INVENTION This application relates to a method and compositions for chemosensitization and radiosensitization of cancer cells through administration of compositions, such as antisense oligonucleotides, which reduce the amount of TRPM-2 in the cells. The invention is of particular

FIELD OF THE INVENTION This application relates to a method and compositions for chemosensitization and radiosensitization of cancer cells through administration of compositions, such as antisense oligonucleotides, which reduce the amount of TRPM-2 in the cells. The invention is of particular

It is known, that throughout life of a mammal or a human being, testosterone/estrone ratios do have a considerable effect on mammal or human life. This testosterone/estrone ratio will exert a powerful and considerable reactions to the emotional well being, as well as in sexual functions, libido,